Challenges in the health economics of familial hypercholesterolemia. - PubMed - NCBI

Challenges in the health economics of familial hypercholesterolemia. - PubMed - NCBI

Curr Opin Lipidol. 2016 Dec;27(6):563-569.

Challenges in the health economics of familial hypercholesterolemia.

Norman R1, Watts GF, Weintraub W, Gidding SS.

Author information

Abstract

PURPOSE OF REVIEW:

Implementation of effective interventions often requires evidence regarding value, that is, whether they are worth what we pay for them. This review explores recent evidence concerning cost-effectiveness in familial hypercholesterolemia, and discusses the cause of, and likelihood of solutions to, the paucity of such evidence.

RECENT FINDINGS:

Cost-effectiveness analysis in familial hypercholesterolemia has been limited almost exclusively to adult populations. However, there is growing evidence that childhood intervention offers substantial benefit in terms of downstream health gains. Statin therapy in adults has been demonstrated to be cost-effective, but the range of novel agents that might be used will require de novo economic evaluation alongside exploration of their effect and safety profile.

SUMMARY:

The familial hypercholesterolemia field has limited evidence regarding cost-effectiveness, which limits optimum allocation of resources. Economic evaluations are necessary to appraise new agents and optimal timing of management approaches. Evaluations often have substantial data demands; consequentially, their applicability to medical decision-making or policy will be partly determined by the availability of data, particularly those providing information about the long-term trajectory of health benefit from familial hypercholesterolemia treatment.

PMID:

 

27798488

 

DOI:

 

10.1097/MOL.0000000000000365

[PubMed - in process]

Public Health Genomics Knowledge Base (v1.2)

Last Posted: Nov-04-2016 2PM

 Familial Hypercholesterolemia expanded expanded

Testing toddlers for inherited heart disease 
Genomics Education UK, October 31, 2016

Test cholesterol of one-year-olds to prevent early heart attacks, study suggests 
The Guardian, October 26, 2016

What Should Be the Screening Strategy for Familial Hypercholesterolemia
BW McCrindle et al, NEJM, October 26, 2016

More information on this topic

Last Updated: Nov 04, 2016

• Testing toddlers for inherited heart disease 
  Genomics Education UK, October 31, 2016
• Challenges in the health economics of familial hypercholesterolemia.
  Norman Richard et al. Current opinion in lipidology 2016 Oct
• Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship.
  Sánchez-Hernández Rosa M et al. Circulation. Cardiovascular genetics 2016 Oct
• Referral Patterns and Cascade Screening for Familial Hypercholesterolemia in a Pediatric Lipid Clinic.
  Stempel Hilary et al. The Journal of pediatrics 2016 Nov 178285-287
• Test cholesterol of one-year-olds to prevent early heart attacks, study suggests 
  The Guardian, October 26, 2016
• Child–Parent Familial Hypercholesterolemia Screening in Primary Care
  DS Wald et al, NEJM, October 26, 2016
• What Should Be the Screening Strategy for Familial Hypercholesterolemia
  BW McCrindle et al, NEJM, October 26, 2016
• Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
  Wald David S et al. The New England journal of medicine 2016 Oct 375(17) 1628-1637
• The panorama of familial hypercholesterolemia in Latin America: a systematic review.
  Mehta Roopa et al. Journal of lipid research 2016 Oct
• Universal Cholesterol Screening in Childhood: A Systematic Review.
  Smith Anna Jo et al. Academic pediatrics 16(8) 716-725
• What Should Be the Screening Strategy for Familial Hypercholesterolemia?
  McCrindle Brian W et al. The New England journal of medicine 2016 Oct 375(17) 1685-1686
• Systematic analysis of variants related to familial hypercholesterolemia in families with premature myocardial infarction.
  Brænne Ingrid et al. European journal of human genetics : EJHG 2016 Feb 24(2) 191-7
• Familial hypercholesterolemia among unselected contemporary patients presenting with first myocardial infarction: Prevalence, risk factor burden, and impact on age at presentation.
  Mortensen Martin Bødtker et al. Journal of clinical lipidology 10(5) 1145-1152.e1
• Familial hypercholesterolemia in a large ambulatory population: Statin use, optimal treatment, and identification for advanced medical therapies.
  Knickelbine Thomas et al. Journal of clinical lipidology 10(5) 1182-7
• US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.
  Ahmad Zahid S et al. Journal of clinical lipidology 10(5) 1223-9

• CDC Information (4)
• CDC-Authored Pub (1)

• Human (66)
• Pathogen (0)

• Human (253)
• Pathogen (0)

• Human (63)
• Pathogen (0)

• Guidelines (7)
• Tier Table (1)
• Synthesis (19)

• Huamn (44)
• Pathogen (0)

Relevant Resources

• Cancer Genomics and Epidemiology Navigator (CGEN)
• Genetics and Genomics Competencies Center (G2C2)
• NIH Genetic Testing Registry
• NIH MedGen Database
• Online Mendelian Inheritance in Man (OMIM)
• PharmGKB